All News

Sometimes even the simplest cases take on a life of their own. When a patient suffers a postoperative complication, but she's had two surgeries by two specialists in a short period of time, the disagreement between those specialists as to how the complication occurred, and in which surgery it occurred, can turn a straightforward "risk of the procedure" case into a medical mystery.

Recent FDA label changes that put to rest safety concerns about IUDs make them an excellent first-line contraceptive option for most of your patients-even those not in a monogamous relationship.

Recent FDA label changes that put to rest safety concerns about IUDs make them an excellent first-line contraceptive option for most of your patients-even those not in a monogamous relationship.

Obstetricians usually date pregnancies in weeks, from the first day of the last menstrual period.

Dr. Bergh believes single embryo transfer can yield satisfactory delivery rates-but at a price, while Dr. Grainer says we should consider several serious scientific and ethical flaws.

We know that tocolytic agents effectively inhibit uterine contractions, but the evidence for improved perinatal outcomes is much less clear. Why is this so, and what are the implications for your patients?

The Internet has empowered individuals who can now access a huge treasure chest of information quickly. This new age has extraordinary implications for ob/gyns.

‘Overactive bladder’ (OAB) may include increased frequency of urination, urinary urgency, and urge-related incontinence symptoms that occur either alone or in combination.

Understanding the pathophysiology of chemokine secretion in endometriosis may offer a novel area of therapeutic intervention. This study aimed to identify chemokines differentially expressed in epithelial glands in eutopic endometrium from normal women and those with endometriosis, and to establish the expression profiles of key chemokines in endometriotic lesions.

A 53 year old woman was investigated for secondary amenorrhea at age 26 and found to have hyperprolactinemia. She took therapy with bromocriptine only for three short periods when she wanted to conceive.

Questions this month have been answered by:Simon Kipersztok, MD, OBGYN.net Osteoporosis Editorial AdvisorHarvey S. Marchbein, MD, USA, OBGYN.net Osteoporosis Chairman and Editorial Advisor

Questions this month have been answered by:R. Wayne Whitted, M.D., M.P.H OBGYN.net Osteoporosis, Editorial AdvisorPaul D. Burstein, M.D., FACOG OBGYN.net Osteoporosis, Editorial Advisor

How useful a role might U/S play in full-term laboring patients for estimating fetal weight, assessing the cervix, and determining fetal position?

Unless operative vaginal delivery can be made at least as safe as cesarean delivery, it will be difficult to justify its continued existence. Proper technique is paramount.

While experts continue to debate the clinical value of electronic fetal monitoring, there's little doubt it's here to stay. Avoiding these 5 common missteps may help you also avoid some common legal minefields.

The cost of malpractice premiums threatens our specialty's very survival. Yet powerful interest groups impede tort reform. What if, however, physicians concede the point that tort reform is not our priority? A strategy of if we can't beat them, join them might ultimately prove the key to the enduring solutions that we seek.

Clinical situations that typically result in litigation and the variation in jury verdicts and awards across the nation.

After reading the latest report from the Women's Health Initiative (WHI), I've struggled with my emotional reaction. The data in this report is not new. The risk of CHD was present only in the oldest women in the trials. . .

Words hurt! We need to choose our words carefully to avoid causing patients unnecessary pain and angst. Your patients will thank you!

The latest in medical products for obstetrics and gynecology.

from The North American Menopause Society: The position statement evaluates the risk-benefit ratio of peri- and postmenopausal estrogen therapy and estrogen-progestogen therapy for both treatment of menopause-related symptoms and disease prevention.

Interstitial cystitis (IC) is a chronic bladder disorder, with symptoms including pelvic and or perineal pain, urinary frequency, and urgency.

Many critics blame technology for skyrocketing healthcare costs in the US. It is rare to find new technology that clearly improves clinical outcomes while lowering the cost of care.

The latest in medical products for obstetrics and gynecology

Array-based comparative genomic hybridization detects significantly more and smaller abnormalities than standard chromosome analysis. Already in limited use, the test may well replace karyotyping for prenatal diagnosis of genetic disorders.

Will robotics revolutionize our field as it has for urology? These experts foresee an exciting decade ahead for more diverse and complex minimally invasive procedures.

In this time of therapeutic innovation for women with fibroids and their ob/gyns, two experts discuss the pros and cons of these minimally invasive options.

After thromboembolic disease, preeclampsia is the second most common cause of maternal death in the US. Although the condition can't be prevented, early identification of women at risk for developing it would enable obstetricians to improve clinical outcomes for both mother and child. With the recent identification of angiogenic factors present in high concentrations in the urine of women at risk, a urinary screening test may soon be a reality.